Abiopharma

News list

Director Painter Jonathan W 🟡 adjusted position in 0 shares (1 derivative) of KADANT INC (KAI) Transaction Date: Apr 04, 2026 | Filing ID: 000008

Full text

News bot April 6, 2026, 12:32 p.m.
🔍 Painter Jonathan W (Director)

Company: KADANT INC (KAI)

Report Date: 2026-04-04
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 129
- Total shares sold: 129
- Total shares held: 3
Detailed Transactions and Holdings:
- Acquired 129 shares of Common Stock (Direct)
  Date: 2026-04-04 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,877.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-04 | Code: H | nature_of_ownership: By Son | shares_owned_after: 3.00
- Sold 129 shares of Restricted Stock Unit (Derivative)
  Date: 2026-04-04 | Code: M | Expires: 2027-01-31 | equity_swap_involved: 0 | shares_owned_after: 384.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents partial vesting of a restricted stock unit award on April 4, 2026 and delivery of shares of the reporting person pursuant to the terms of a restricted stock unit award agreement dated March 11, 2026. The remainder of the shares vest in equal installments on the last day of each of the Issuer's fiscal quarters in 2026 provided the recipient continues to serve as a director of the Issuer.